Skip to content

Morphine may protect against HIV-related brain disease

Rilpivirine proves non-inferior to efavirenz in phase 3 studies

Anti-HIV drugs inhibit emerging virus linked to prostate cancer and chronic fatigue syndrome

Acne drug prevents HIV activation from latently infected cells

South Africa: Delayed drug registrations hard to swallow

CCR5 antagonist vicriviroc fails to surpass potent background regimen

New CCR5 antagonist TBR-652 shows good antiviral activity in early study

Elvitegravir 'Quad' pill performs well, new booster cobicistat works as well as ritonavir

Tesamorelin safe and effective for fat accumulation in patients taking HIV treatment